Pain Drug Delivery Market - Pmr Market Insight Report 2016 to 2022
- Submitted by: justinbarnes123
- Views: 74
- Category: Other
- Date Submitted: 02/07/2016 11:53 PM
- Pages: 4
- Report this Essay
Pain Drug Delivery Market - PMR Market Insight Report 2016 to 2022
Persistence Market Research
Pain Drug Delivery Market - PMR Market
Insight Report 2016 to 2022
Persistence Market Research
1
Pain Drug Delivery Market - PMR Market Insight Report 2016 to 2022
Persistence Market Research Released New Market Report on “Pain Drug Delivery
Market - PMR Market Insight Report 2016 to 2022”.
Pain drug delivery system is an effective therapy for managing pain, whether it be a
chronic nonmalignant pain, a cancer pain, or a spasticity. Medications usually
circulate throughout the body in bloodstream, whereas pain drug delivery systems
releases medication directly into the fluid surrounding the spinal cord, which leads
to fewer drug side effects. Pain drug delivery systems help lessen chronic pain
caused by failed back surgery syndrome, cancer pain, reflex sympathetic dystrophy,
causalgia, arachnoiditis, and chronic pancreatitis. Such drug delivery systems used
for pain management also helps reduce the spasticity caused by cerebral palsy,
multiple sclerosis, stroke, brain injury and spinal cord injury among others. Pain drug
delivery systems do not eliminate the source of pain or cure any underlying disease,
but help to manage the pain.
According to the British journal of anesthesia, prevalence of chronic pain is higher
for instance, 10.1%-55.2% of the population in 2010. In U.S., about 30% of the
population is suffering from chronic or recurring pain. Approximately, two-third of
the population experience chronic pain for more than 5 years. In U.S., the cost of
chronic pain is approximately US$100 billion a year. Growing prevalence of various
types of cancers is a major factor driving the market. For instance, there were an
estimated 14.1 million cancer cases around the world in 2012. As per WHO
statistics, this number is expected to increase to 24 million by 2035. Also rising
geriatric population, increasing prevalence of diseases such as osteoarthritis,
diabetic...
Persistence Market Research
Pain Drug Delivery Market - PMR Market
Insight Report 2016 to 2022
Persistence Market Research
1
Pain Drug Delivery Market - PMR Market Insight Report 2016 to 2022
Persistence Market Research Released New Market Report on “Pain Drug Delivery
Market - PMR Market Insight Report 2016 to 2022”.
Pain drug delivery system is an effective therapy for managing pain, whether it be a
chronic nonmalignant pain, a cancer pain, or a spasticity. Medications usually
circulate throughout the body in bloodstream, whereas pain drug delivery systems
releases medication directly into the fluid surrounding the spinal cord, which leads
to fewer drug side effects. Pain drug delivery systems help lessen chronic pain
caused by failed back surgery syndrome, cancer pain, reflex sympathetic dystrophy,
causalgia, arachnoiditis, and chronic pancreatitis. Such drug delivery systems used
for pain management also helps reduce the spasticity caused by cerebral palsy,
multiple sclerosis, stroke, brain injury and spinal cord injury among others. Pain drug
delivery systems do not eliminate the source of pain or cure any underlying disease,
but help to manage the pain.
According to the British journal of anesthesia, prevalence of chronic pain is higher
for instance, 10.1%-55.2% of the population in 2010. In U.S., about 30% of the
population is suffering from chronic or recurring pain. Approximately, two-third of
the population experience chronic pain for more than 5 years. In U.S., the cost of
chronic pain is approximately US$100 billion a year. Growing prevalence of various
types of cancers is a major factor driving the market. For instance, there were an
estimated 14.1 million cancer cases around the world in 2012. As per WHO
statistics, this number is expected to increase to 24 million by 2035. Also rising
geriatric population, increasing prevalence of diseases such as osteoarthritis,
diabetic...